中药单体和复方干预强直性脊柱炎的相关信号通路研究进展
x

请在关注微信后,向客服人员索取文件

篇名: 中药单体和复方干预强直性脊柱炎的相关信号通路研究进展
TITLE: Research advances on traditional Chinese medicine monomers and compounds intervening in ankylosing spondy-litis-related signaling pathways
摘要: 强直性脊柱炎是一种以脊柱和骶髂关节为主要受累部位的慢性免疫炎症性疾病,与骨保护素(OPG)/核因子κB(NF-κB)受体激活因子(RANK)/RANK配体、促分裂原活化的蛋白质激酶(MAPK)、Wnt/β-连环蛋白(β-catenin)、磷脂酰肌醇3激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白(PI3K/Akt/mTOR)等信号通路密切相关。中药具有多成分、多靶点的特点,因其毒性低、特异性强、疗效高而被广泛应用于自身免疫性疾病的治疗。本文综述发现,中药单体和复方可通过干预上述信号通路,调节免疫炎症反应,抑制骨破坏、异位成骨分化、细胞凋亡和自噬等生物学过程发挥抗强直性脊柱炎的作用。
ABSTRACT: Ankylosing spondylitis is a chronic immunoinflammatory disease that mainly affects the spine and the sacroiliac joint, the mechanism of which is closely related to signaling pathways, such as osteoprotegerin (OPG)/receptor activator of nuclear factor-κB (RANK)/RANK ligand, mitogen-activated protein kinase (MAPK), Wnt/β-catenin (β-catenin), phosphoinositide 3- kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR). Traditional Chinese medicine has the characteristics of multiple components and targets, and is widely used for the treatment of autoimmune diseases due to its low toxicity, strong specificity, and high efficacy. This review found that monomers and compounds of traditional Chinese medicine can exert anti ankylosing spondylitis effects by intervening in the aforementioned signaling pathways, regulating immune inflammatory responses, and inhibiting biological processes such as bone destruction, ectopic osteogenic differentiation, cell apoptosis, and autophagy.
期刊: 2025年第36卷第03期
作者: 周海东;卢姚宏;胡梁深;龚礼;林茂华;郝仕鹏;言建宾;陈伟辉;范少勇
AUTHORS: ZHOU Haidong, LU Yaohong,HU Liangshen,GONG Li,LIN Maohua,HAO Shipeng,YAN Jianbin,CHEN Weihui,FAN Shaoyong
关键字: 中药;复方;单体;强直性脊柱炎;信号通路;免疫
KEYWORDS: traditional Chinese medicine; compound; monomer; ankylosing spondylitis; signaling pathway; immune
阅读数: 9 次
本月下载数: 0 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!